| Literature DB >> 19596887 |
Jérôme Boissier1, Frédéric Coslédan, Anne Robert, Bernard Meunier.
Abstract
We report the in vitro activities of trioxaquines against larval and adult-stage schistosomes at 5 and 50 microg/ml, respectively. Such activities are equivalent to that of praziquantel, the major and rather unique drug currently used for the treatment of schistosomiasis. In this range of concentrations, artemisinin derivatives (artesunate and artemether) have no activity.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19596887 PMCID: PMC2772302 DOI: 10.1128/AAC.00640-09
Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN: 0066-4804 Impact factor: 5.191